文献速递肺栓塞与肺血管病间质性肺疾病

微粒在系统性硬化症中:潜在的促炎介质与肺动脉高压生物标志物

Microparticles in systemic sclerosis: Potential pro-inflammatory mediators and pulmonary hypertension biomarkers.
PubMed 文献 · Respirology · 2019-02-12

本研究比较了系统性硬化症合并肺动脉高压、无肺动脉高压及健康对照三组的循环内皮微粒水平,并体外暴露人肺动脉内皮细胞于患者微粒,发现CD144+内皮微粒对SSc相关PAH有诊断价值,且患者微粒可诱导内皮炎症。

要点

  • CD144+内皮微粒在SSc-PAH组显著高于SSc无PH组和健康对照,诊断准确率80%。
  • SSc患者CD31+/CD62E+比值升高,提示凋亡是内皮微粒释放的重要机制。
  • SSc患者来源微粒可上调肺动脉内皮细胞炎性细胞因子和黏附分子。

核心结论

  • 内皮微粒(尤其CD144+)是SSc相关PAH有前景的生物标志物,但仍需进一步研究。
  • SSc患者来源微粒可诱导内皮细胞炎症,可能是SSc的重要致病因素。

研究设计与样本

  • 三组对照研究:10例SSc合并PAH、10例SSc无PH、10例年龄性别匹配健康对照。
  • 体外实验:人肺动脉内皮细胞暴露于SSc患者或健康对照来源微粒,比较细胞因子和炎性黏附分子水平。

主要发现

  • CD144+内皮微粒在SSc-PAH组显著高于SSc无PH组和健康对照,诊断准确率80%(P=0.02)。
  • SSc患者CD31+/CD62E+比值高于对照,提示凋亡对微粒释放贡献更大(P=0.04)。
  • 局限型SSc患者CD143+内皮微粒水平显著高于弥漫型(P=0.008)。
  • 人肺动脉内皮细胞暴露于SSc患者微粒后炎性细胞因子和黏附分子显著增加。
  • 暴露于健康对照微粒则炎性标志物减少。

临床怎么用

  • CD144+内皮微粒有望作为SSc患者筛查PAH的候选生物标志物,但尚不能常规用于临床。
  • SSc患者微粒诱导的内皮炎症提示微粒可能参与SSc血管病变,为未来靶向治疗提供线索。

局限性

  • 每组样本量仅10例,结果需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Endothelial microparticles (EMP) are submicron vesicles released from endothelial cells. We aimed to determine the utility of EMP as biomarkers of pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) patients and the pathogenic role of microparticles (MP) in vascular inflammation. METHODS: Levels of EMP (CD144+, CD31+, CD62E+ and CD143+) were compared between three groups (10 SSc patients with PAH, 10 SSc patients without pulmonary hypertension (no-PH) and 10 healthy age- and sex-matched controls). Human pulmonary artery endothelial cells (HPAEC) were exposed in vitro to MP obtained from SSc patients or healthy controls, and levels of cytokines and inflammatory adhesion molecules were compared. RESULTS: CD144+ EMP were significantly higher in the SSc-PAH group compared to either the SSc-no PH or healthy controls (diagnostic accuracy 80%, P = 0.02). Compared to controls, SSc patients had higher CD31+/CD62E+ ratios, indicating larger contributions of apoptosis to EMP release (P = 0.04). Patients with limited SSc had significantly higher levels of CD143+ EMP compared to those with diffuse subtype (P = 0.008). When HPAEC were exposed to MP from SSc patients, there was a significant increase in inflammatory cytokines and adhesion molecules. Interestingly, exposure to healthy control MP caused a reduction in inflammatory markers. CONCLUSION: EMP (particularly CD144+) are promising biomarkers of PAH in SSc but require further study. MP isolated from SSc patients induced an increase in endothelial cell inflammation and may be an important pathogenic factor in SSc.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Lammi MR, Saketkoo LA, Okpechi SC, et al. Microparticles in systemic sclerosis: Potential pro-inflammatory mediators and pulmonary hypertension biomarkers. Respirology. 2019. PMID: 30747487. doi:10.1111/resp.13500

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。